Assignee: Euroceltique, S.A.

Location: LU
No. of patents: 40

Browse patents
Browse applications

Number	Title	Issue Date
7256193	Therapeutic agents useful for treating pain A Compound of formula (wherein X is O or S and R1-R5 are disclosed herein) or a pharmaceutically acceptable salt thereof (each being a “Piperazine Compound”), pharmaceutical compositions...	08/14/2007
7202259	Therapeutic agents useful for treating pain 4-Tetrazolyl-4-phenylpiperidine Compounds, compositions comprising an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound, methods for treating or preventing pain or diarrhea in an animal comprising administering to an animal in need thereof an effective ...	04/10/2007
7125561	Compartmentalized dosage form The present invention provides provide a dosage form that prevents misuse of the medicament contained within. The dosage form contains an inactivating substance in combination with the medicament, wherein the two substances are separated by a permeable or semi-perme...	10/24/2006
7075645	Spectroscopic analyzer for blender A blending apparatus comprises a blender including a container having a wall, the wall including a window. The container rotates about an axis of rotation. A wireless spectrometer is mounted to the container and operates through the window, in a direction that does ...	07/11/2006
6995168	Triazaspiro compounds useful for treating or preventing pain Triazaspiro Compounds, compositions comprising a Triazaspiro Compound, methods for treating or preventing pain in an animal comprising administering to an animal in need thereof an effective amount of a Triazaspiro Compound and methods for stimulating opioid-recepto...	02/07/2006
6974818	1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain A compound of formula: (wherein X is O or S and R1, R3, R4, and R5 are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Thiadiazolylpiperazine Compound�...	12/13/2005
6864261	Therapeutic agents useful for treating pain A compound of formula (wherein A, R1, R2, R6, m and n are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Piperazine Compound”); pharmaceutical compositions comp...	03/08/2005
6841792	ATR crystal device The present invention includes an ATR crystal system comprising: an ATR crystal, one face of the ATR crystal forming a portion of an interior surface of a containment vessel, a radiation source for creating a beam or radiation, the radiation sources optically connec...	01/11/2005
6828440	Spiroindene and spiroindane compounds A compound of the formula (I): wherein Z, A, B, C, R1, R2, X1, X2, Q and n are as disclosed herein. ...	12/07/2004
6784319	Synthesis of (±)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols Compositions comprising (±)-2-((dimethylamino)methyl)cyclohexanone, a transition-metal salt, and an organic solvent and methods of preparing (±)-cis-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols, in particular (±)-cis-2-((dimethylamino)methyl)-1-(3-methoxypheny...	08/31/2004
6780853	Neuroactive steroids of the androstane and pregnane series The invention relates to 3α-hydroxy, 17-(un)substituted derivatives of the androstane series and 3α-hydroxy, 21-substituted derivatives of the pregnane series. These derivatives are capable of acting at a recently identified site on the GRC, thereby modulating bra...	08/24/2004
6770661	Aryl substituted pyridines and their use This invention relates to aryl substituted pyridines of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Ar and R1-R4 are set in the specification. The invention...	08/03/2004
6765006	Substituted quinazolines and analogs and the use thereof The invention relates to novel quinazolines and heterocycles which are antagonists or positive modulators of AMPA receptors, and the use thereof for treating, preventing or ameliorating neuronal loss associated with stroke, global and focal ischemia, CNS trauma, hyp...	07/20/2004
6740641	Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain Glucoside and glucuronide derivatives of hydromorphone, dihydromorphine, and dihydroisomorphine and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising a glucoside or glucuronide derivative of hydromorphone, dihydromorphine, or dihydroi...	05/25/2004
6737418	Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof This invention relates to compounds having the Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Het and R5-R13 are set in the specification. The invention also i...	05/18/2004
6479484	Substituted 2-aminoacetamides and the use thereof The invention is directed to substituted 2-aminoacetamides represented by formula (II): ##STR1## and to pharmaceutically acceptable salts and prodrugs thereof, wherein the substituents are defined herein. The invention is also directed to the use of ...	11/12/2002
6444982	Dissolution stage for an environmental scanning electron microscope A system is provided for imaging, in an ESE microscope or other variable pressure microscope, a single sample at various time intervals during dissolution of the sample in a liquid. The system includes a sample chamber having a sample well. The sample wel...	09/03/2002
6365606	6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess improved PDE IV inhibition compared to theophylline or rolipram, with improved selectivity with regard to, e.g., PDE V inhibition. The present invention includes co...	04/02/2002
6310205	Hypoxathine compounds Hypoxanthine compounds of the structure: ##STR1## are disclosed where R3 and R8 are as described herein. The compounds are useful as intermediates to compounds providing PDE IV inhibition activity....	10/30/2001
6166041	2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma Novel compounds which are effective PDE IV inhibitors are disclosed. The present invention is directed to compounds having the general formula I ##STR1## wherein: X is a halogen; Q is --CH2 --CH2 --, --CH2 --, a single or ...	12/26/2000
6057445	Purine compounds having PDE IV inhibitory activity and methods of synthesis The present invention comprises methods of synthesizing compounds having the formula I: ##STR1## wherein: Y1, Z, R1, R2, R3, R4 and R8 are as described herein, which comprises the step...	05/02/2000
5863556	Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds The present invention relates to liposomal pharmaceutical preparations which include active agents such as antiseptic agents, wound-healing agents, or combinations thereof, useful in the treatment of external wounds. The active agents are encapsulated in ...	01/26/1999
5639476	Controlled release formulations coated with aqueous dispersions of acrylic polymers A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent...	06/17/1997
5601845	Pharmaceutical spheroid formulation A controlled release composition including spheroid cores of diltiazem. or a pharmaceutically acceptable salt thereof and optionally a spheronizing agent, the cores being coated with a controlled release layer, and a method of manufacturing the same, is d...	02/11/1997
5580578	Controlled release formulations coated with aqueous dispersions of acrylic polymers A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent...	12/03/1996
5508044	Diltiazem pharmaceutical spheroid formulation A solid oral dosage form comprising diltiazem (or a pharmaceutically acceptable salt thereof) in controlled release form and hydrochlorothiazide in immediate release form. Preferably, the controlled release component comprises a plurality of spheroids com...	04/16/1996
5500227	Immediate release tablet cores of insoluble drugs having sustained-release coating A controlled release tablet for oral administration is disclosed which has a tablet core including an insoluble therapeutically active agent having an aqueous solubility of less than or equal to about 5 mg/ml in a sufficient amount to render a therapeutic...	03/19/1996
5478577	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level Patients are treated with 24-hour oral sustained release opioid formulations which upon administration quickly release an effective portion of the opioid contained therein such that there is an initially more rapid opioid release so that the minimum effec...	12/26/1995
5472712	Controlled-release formulations coated with aqueous dispersions of ethylcellulose A stabilized solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic polymer is obtained by overcoating a substrate including an active agent selected from the group consisting of a systemically active the...	12/05/1995
5286493	Stabilized controlled release formulations having acrylic polymer coating A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of an acrylic polymer is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of the plasticized acrylic pol...	02/15/1994
5266331	Controlled release oxycodone compositions A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of oxycodone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method of 100 ...	11/30/1993
5217965	Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions The stability of compositions of choline salicylate-metal salicylate-carboxymethylcellulose is improved by the incorporation therein of microcrystalline cellulose. The microcrystalline cellulose is linked to the remainder of the composition by liquid brid...	06/08/1993
5215758	Controlled release matrix suppository for pharmaceuticals The controlled release of therapeutically active agents is achieved from a controlled release matrix of sodium alginate and a calcium salt. When the composition is to be administered rectally, the matrix is combined with a therapeutically active agent and...	06/01/1993
5152742	Swab apparatus Swab apparatus for use in topical application of treatment materials comprise a swab, a flexible-walled container having an interior in which a quantity of treatment material is situated, and a coupling tube having a forward end portion to which the swab ...	10/06/1992
5112515	Phenothrin shampoo The invention relates to a lousicidal shampoo composition of phenothrin as lousicidal agent distributed in a shampoo base of water and one or more surface active agents, the shampoo containing as antimicrobial preservative 2-bromo-2-nitropropane-1,3-diol ...	05/12/1992
5071646	Pharmaceutical ion exchange resin composition An ion exchange resin composition which is readily dispersible in water is provided. This resin composition comprises a granulated ion exchange resin, a pharmacologically active ingredient bound thereto with a sugar or sugar alcohol, and a sufficient amou...	12/10/1991
4954351	Method of producing standardized povidone iodine preparations and such preparations A pharmaceutical iodophor preparation having predictable microbicidal effectiveness and long duration of action comprising polyvinylpyrrolidone-iodine (PVPI), free iodine, a source of iodide ions and a source of iodate ions, the preparation having a ratio...	09/04/1990
4950653	Solid iodophor composition A solid iodophor composition contains a water-soluble iodophor, especially povidone iodine, and at least one of a urea and a sugar alcohol, especially mannitol, sorbitol or xylitol. The composition may also contain a sugar such as sucrose or lactose. The ...	08/21/1990
4946673	Iodine-containing germicidal preparations and method of controlling germicidal activity Iodine-containing germicidal preparations are provided with assured control of the content of equilibrium iodine in aqueous solution to be between 1 and 20 ppm, preferably 2-15 ppm so as to provide predetermined germicidal activity. The invention further ...	08/07/1990
4925847	6-thioxanthines A 6-thioxanthine of general formula I or a pharmaceutically acceptable salt thereof ##STR1## wherein R3 is a C2 to C6 alkyl, a C3 to C7 cycloalkyl group or a C4 to C8 cycloa...	05/15/1990

PatentStorm

Bizarre Patents

PatentStorm News

Assignee: Euroceltique, S.A.